Children with Chronic Lung Disease: Facilitating Smoking Cessation for their Caregivers

Objectives: Determination rate of smoking and some related factors to the accessibility of counseling and smoking cessation services in patients with chronic lung disease at Nga Nam Medical Center, Soc Trang in 2020. Subjects and research methods: Cross-sectional descriptive study with analysis. The toolkit is based on “The Ministry of Health’s 2018 Tobacco Harm Prevention Guidelines” and related research. Results and discussions: The smoking rate of patients is 59.9%. The number of people accessing tobacco cessation counseling services is lowing with 29.9%. The results of multivariate logistic regression analysis showed that have relationship between the ability to access counseling services, smoking cessation and smoking (OR = 0.042; p < 0.005), gender (OR = 0.067; p < 0.005), occupation (p < 0.005). Conclusions and recommendations: Patients need to actively learn about the harmful effects of smoking as well as smoking cessation methods and services. The health sector needs to develop plans and provide counseling and smoking cessation services for patients. When educating, it is necessary to pay attention to the patient's psychology, gender and occupation.

Download Full-text

Nicotine and Tobacco

ASAM Handbook of Addiction Medicine ◽

10.1093/med/9780197506172.003.0007 ◽

2020 ◽

pp. 149-182

Author(s):

Shadi Nahvi ◽

Darius A. Rastegar

Keyword(s):

Cardiovascular Disease ◽

Carbon Monoxide ◽

Smoking Cessation ◽

Lung Disease ◽

Tobacco Use ◽

Chronic Lung Disease ◽

Electronic Cigarettes ◽

Withdrawal Symptoms ◽

Tobacco Products ◽

Exhaled Carbon Monoxide

Nicotine is responsible for the psychoactive and habit-forming effects of tobacco. Approximately 30% of Americans use tobacco products; half of them are nicotine-dependent. Nicotine has mild stimulant effects. Overdose is rare in experienced users. Some may develop nausea, vomiting, weakness, and dizziness. Withdrawal symptoms include craving, irritability, anxiety, restlessness, and increased appetite. Smokers have elevated exhaled carbon monoxide and serum carboxyhemoglobin levels. Cotinine, a metabolite of nicotine, can be detected in blood and urine. Many medical conditions are associated with tobacco use (particularly smoking), including cardiovascular disease, chronic lung disease, and a variety of malignancies. A number of interventions can help increase smoking cessation rates, including physician advice, counseling, nicotine replacement, varenicline, and bupropion. Electronic cigarettes may help smokers quit or reduce their smoking.

Download Full-text

Evaluation of Treatment Results in Patients with a History of Acute or Chronic Lung Disease Admitted to the Smoking Cessation Clinic

Journal of İzmir Chest Hospital ◽

10.5222/igh.2020.21931 ◽

2020 ◽

Author(s):

Mustafa Çolak ◽

Mehmet Ali Aslaner

Keyword(s):

Smoking Cessation ◽

Lung Disease ◽

Chronic Lung Disease ◽

Chronic Respiratory Disease ◽

Treatment Results ◽

Similar Treatment ◽

Significant Difference ◽

History Of ◽

Cessation Clinic ◽

Smoking Cessation Clinic

INTRODUCTION: We aimed to evaluate the treatment results of patients with a history of lung disease evaluated in our smoking cessation clinic. METHODS: A total of 112 cases referred to and started treatment at the our smoking cessation polyclinic between the dates of 01.01.2018 and 31.12.2018 were retrospectively examined. RESULTS: The median age of the 112 cases were evaluated was 42, and there was a %72,3 prevalence of the male gender. There was no significant difference in terms of gender distribution between cases with a history of acute or chronic lung disease (p=0,721). There was a history of acute lung disease in %55,4 (n=62) of cases, and chronic lung disease in %44,60 (n=50). Similar treatment agents for smoking cessation were used in both groups. At the end of the three-month follow up period, it was observed that 38 patients (%61,3) in the group with a history of acute lung disease, and 29 facts (%58) in the group with a history of chronic lung disease quit smoking, and there was no statistically significant difference between the groups (p=0,724). DISCUSSION AND CONCLUSION: In our study, we found that acute or chronic respiratory disease did not make a significant differ in the results of smoking cessation treatments.

Download Full-text